Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
January 03, 2025
1 min read
Cencora completed its acquisition of Retina Consultants of America, according to a press release.
At closing, Cencora’s cash outlay was $4.4 billion, including transaction fees and expenses, the repayment of debt and the equity rollover with Retina Consultants of America (RCA), an amount which is subject to post-closing purchase price adjustment. The company updated its adjusted diluted earnings per share guidance range for fiscal year 2025 to a range of $15.15 to $15.45.
Cencora acquired an interest of approximately 85% in RCA.
“The acquisition allows Cencora to build on its leadership in specialty, expand its [management services organization] solutions and drive differentiated value for stakeholders, including physicians and patients,” the company said in the release.
Read more about
Leave a Reply